Search

everythinglearnresearchcommunity

for

Search:↓

Targeting NCoR1 can help treat heart enlargement and dysfunction.

A new genetic mutation linked to Hutchinson-Gilford progeria syndrome was found in China.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

Higher IMA levels in male AGA patients, especially if obese, may link AGA to metabolic and heart issues.

Anabolic-androgenic steroids increase the risk of heart problems.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

People with alopecia areata have a higher risk of heart disease.

Alopecia areata may increase the risk of cardiovascular disease.

Alopecia areata patients, especially with severe forms, have a higher risk of cardiovascular disease.

Abusing anabolic steroids can cause serious health problems despite short-term muscle gains.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Hutchinson-Gilford Progeria Syndrome causes rapid aging due to a gene mutation, with no cure yet, but research may lead to better treatments.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Controlled microflora in animals delays immune cell maturation and affects immunity.

Creating a supportive environment is crucial for repairing heart tissue without using actual heart cells.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

An adult with Kawasaki disease experienced temporary heart failure but recovered without lasting heart damage.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Targeting adipocyte-to-mesenchymal transition could help treat fibrosis.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

bFGF delays hair growth in mice.

Fibroblast behavior is key for skin structure and healing.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Some skin growths with mucin can form hair follicles and resemble skin cancer, but a special stain can help tell them apart.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

Growth factors help hair follicle stem cells grow and stay versatile.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.